Author:
Poh-Fitzpatrick M. B.,Carralero M. Lecha,Doss M. O.,Bickers D. R.,Herrero C.,Mascaró J. M.,Elder G. H.,Sassa S.,Fujita H.,Toback A.,Harber L.,Kappas A.,Lim H. W.,Muniesa A. M.,Lloveras H.,Piomelli S.,Seaman C.,Skolnick L. M.
Publisher
Springer Berlin Heidelberg
Reference128 articles.
1. Ashton RE, Hawk JLM, Magnus IA (1984) Low-dose oral chloroquine in the treatment of porphyria cutanea tarda. Br J Dermatol 111:609–613.
2. Cam C, Nigogosyan G (1963) Acquired toxic porphyria cutanea tarda due to hexachloro-benzene. Report of 348 cases caused by this fungicide. JAMA 183:88–91.
3. Dandurand M, Guillot B, Guilhou J-J (1986) Porphyrie cutanée tardive et néoplasies. A propos de deux observations. Ann Dermatol Venereol 113:679–683.
4. De Verneuil H, Aitken G, Nordmann Y (1978) Familial and sporadic porphyria cutanea. Two different diseases. Hum Genet 42:145–151.
5. De Veneuil H, Sassa S, Kappas A (1983) Effects of polychlorinated biphenyl compounds, 2,3,7,8-tetrachlorodibenzo-p-dioxin, phénobarbital and iron on hepatic uroporphyrinogen decarboxylase. Implications for the pathogenesis of porphyria. Biochem J 214:145–151.